Expanded Cystic Fibrosis Panel

Synonyms

  • CF CARRIER SCREEN
  • CFPLUS
  • CYSTIC FIBROSIS CARRIER SCREEN
  • CYSTIC FIBROSIS EXPANDED PANEL
  • LAB11483

Cerner Name

Expanded Cystic Fibrosis Panel

Clinical Info


Use
This test is used for carrier screening for cystic fibrosis by full gene sequencing and deletion/duplication analysis. 
Variants of uncertain significance are not included.

Specimen Sources

Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous

Specimen Types

Blood

Specimen Volume

4 mL of Whole blood (3mL Min) or PurFlock buccal swab kit or Oragene Dx 500 saliva kit

Container

Lavender Top Tube

Collection Instructions


Container:
Yellow-top (ACD-A) or lavender-top (EDTA) or pink-top (EDTA) or tan-top (EDTA) tubes 
or PurFlock buccal swab kit or Oragene Dx 500 saliva collection kit

Transport Instructions

Room Temperature

Specimen Stability


Stability Requirements
Whole blood: 14 days at room temperature or 30 days Refrigerated
Buccal: 60 days at room temperature
Saliva: 60 days at room temperature

Methodology


Next-generation sequencing: Identifies genetic variants, including small nucleotide variants (SNVs), 
insertions, deletions and copy number variants (CNVs).

Days Performed


TAT: 14 - 21 days 
(In some cases, additional time may be required for confirmatory or reflex tests.)

Performing Laboratories

Labcorp

CPT

81220    

PDM

5906098

Results
Component Name Base Name Common Name External Name
EXPANDED CYSTIC FIBROSIS PANEL CYSTFIBEXPAN EXPANDED CYSTIC FIBROSIS PANEL Expanded Cystic Fibrosis Panel
ETHNICITY-LC ETHNICITY ETHNICITY LC Ethnicity-LC
SPECIMEN TYPE - LC SPECTYPE SPECIMEN TYPE Specimen Type - LC
GENETIC COUNSELOR GENECOUNS GENETIC COUNSELOR Genetic Counselor
INDICATION INDICATION INDICATION Indication
RESULT: RESULT RESULT Result:
INTERPRETATION: INTERP INTERPRETATION Interpretation:
GENERAL COMMENTS GENCOMM GENERAL COMMENTS General Comments
RECOMMENDATIONS-LC RECOMMEND RECOMMENDATIONS Recommendations-LC
ADDITIONAL CLINICAL INFORMATION ADDCLININFO ADDITIONAL CLINICAL INFORMATION Additional Clinical Information
COMMENTS (REF LAB) COMMENTREF COMMENTS REF LAB Comments (Ref lab)
METHOD/LIMITATIONS METHODLIMIT METHOD LIMITATIONS Method/Limitations
REFERENCES REFERENCES REFERENCES References
DIRECTOR REVIEW/RELEASE DIRREVREL DIRECTOR REVIEW RELEASE Director Review/Release

Result Interpretation


 

Forms
Molecular-send outs LAB11483 build edit